Home›Companies›Novascope Biochips

Novascope Biochips Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 11, 2023·Suggest an edit

About Novascope Biochips

Novascope Biochips is a private company based in Scarsdale, New York, incorporated in 2022 in Delaware. It has reported $254,928 raised in two offerings on Form D since February 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 27, 2023Apr 11, 2023$104,928fully sold1$104KEquityRule 506(b)Form D ↗
Feb 1, 2023Feb 9, 2023$150,000fully sold1$150KEquityRule 506(b)Form D ↗
Total, two offerings$254,928

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Novascope Biochips's Form D filed Apr 11, 2023.

YT
Yueh Hsiang Tsai
Executive officer and director

Sources

  1. SECNovascope Biochips Inc. filing history